Search Results 21-30 of 27914 for %EC%88%98%EB%8F%99%EB%B0%94%EB%94%94%ED%94%84%EB%9E%9C%EB%93%9C%EC%95%88%EB%A7%88%EC%9D%98%EC%9E%90/%EC%BD%94%EC%B2%B4/%EC%82%AC%ED%8C%8C%EB%A8%B8%EC%8B%A0/%EC%BD%94%EC%A7%80%EB%A7%88/%ED%98%84%EB%8C%80%EC%84%BC%EC%95%88%EB%A7%88/%EC%97%98%EC%A7%80%E3%80%90KaKaotalk:za32%E3%80%91%EC%84%9C%EC%9A%B8%EC%B6%9C%EC%9E%A5%EC%95%88%EB%A7%88,%EC%84%9C%EC%9A%B8%EC%97%90%EC%8A%A4%ED%94%8C%EB%9F%AC%EC%8A%A4,%EC%84%9C%EC%9A%B8%EC%B6%9C%EC%9E%A5%EC%97%85%EC%86%8C,%EC%84%9C%EC%9A%B8%ED%99%8D%EB%93%B1%EA%B0%80,%EC%84%9C%EC%9A%B8%EC%BD%9C%EA%B1%B8
Stoeckman AK, Baechler EC, Ortmann WA, Behrens TW, Michet CJ, Peterson EJ. A distinct inflammatory gene expression profile in patients with psoriatic arthritis.
Olive EJ, Glasgow AE, Habermann EB, Gebhart JB, Occhino JA, Trabuco EC, Linder BJ. ... Hokenstad ED, Habermann EB, Glasgow AE, Occhino JA. ... 2008 Fall; 24(3):93- ...
93 · 94 · 95 · 96 · 97 ... Next · Last · Study assesses opioid usage patterns in patients with lupus. Systemic lupus erythematosus (SLE)—a challenging ...
LGBTQ-Affirmative Behavioral Health Services in. Primary Care. Prim Care. 2021 Jun;48(2):243-257. 84. Hill JC, Njeru JW, Wieland ML, Rutten LJ, ...
PubMed - Enzyme Replacement Therapy in a Patient with Gaucher Disease Type III.
The purpose of this study is to evaluate digital tomosynthesis (3-D) mammography and digital mammography in screening patients for breast cancer.
From November through January, a host of holidays tempt us with festive foods and beverages. If the treats are hard to resist, you're not alone[...].
This phase II trial studies how well trastuzumab emtansine works in treating older patients with human epidermal growth factor receptor 2 (HER2)-positive ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.